HWAM
FULC icon

Hennion & Walsh Asset Management’s Fulcrum Therapeutics FULC Stock Holding History

Hennion & Walsh Asset Management’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$856K Buy
+233,851
New +$1.42M 0.02% 606

Other funds holding FULC

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CP
Castleview Partners Dallas, Texas $228M AUM 19.85% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Hennion & Walsh Asset Management's FULC Position: Q2 2026 in Review

Hennion & Walsh Asset Management opened a new position in Fulcrum Therapeutics (FULC) in Q2 2026: 233,851 shares worth $856K. The stake represents 0.02% of the portfolio and ranks #606 among its holdings.

12 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Hennion & Walsh Asset Management held 233,851 shares of Fulcrum Therapeutics worth $856K as of Q2 2026.
  • Fulcrum Therapeutics was a new Hennion & Walsh Asset Management position in Q2 2026.
  • Fulcrum Therapeutics made up 0.02% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #606 holding.
  • 12 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.